Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.060 |
None |
1.000 |
6 |
|
2004 |
2020 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.060 |
None |
1.000 |
6 |
|
2004 |
2020 |
early pregnancy
|
phenotype |
|
Disease or Syndrome
|
273
|
8
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2020 |
Hypertensive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
2322
|
1085
|
0.700 |
None |
0.964 |
56 |
2
|
1995 |
2019 |
Apparent mineralocorticoid excess
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
23
|
15
|
0.800 |
strong |
0.981 |
52 |
15
|
1995 |
2019 |
Fetal Growth Retardation
|
phenotype |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications
|
Disease or Syndrome
|
1037
|
21
|
0.400 |
None |
1.000 |
13 |
|
2001 |
2019 |
Mineralocorticoid Excess Syndrome, Apparent
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
8
|
1
|
0.550 |
None |
1.000 |
7 |
1
|
1996 |
2019 |
Hyperaldosteronism
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
84
|
6
|
0.070 |
None |
1.000 |
7 |
|
1999 |
2019 |
Anxiety
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1048
|
287
|
0.040 |
None |
1.000 |
4 |
|
2012 |
2019 |
Anxiety Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
840
|
163
|
0.040 |
None |
1.000 |
4 |
|
2012 |
2019 |
Cushing Syndrome
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
126
|
9
|
0.040 |
None |
1.000 |
4 |
|
2003 |
2019 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.030 |
None |
1.000 |
3 |
|
2002 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2019 |
Osteopenia
|
disease |
Nutritional and Metabolic Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
845
|
61
|
0.020 |
None |
0.500 |
2 |
|
2018 |
2019 |
Osteoporosis
|
disease |
Nutritional and Metabolic Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
1098
|
182
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Skin carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
136
|
24
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Chronic Kidney Diseases
|
group |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
1074
|
306
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Hormone refractory prostate cancer
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
683
|
29
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Cystic Fibrosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases; Respiratory Tract Diseases
|
Disease or Syndrome
|
852
|
704
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Progression of prostate cancer
|
disease |
|
Neoplastic Process
|
398
|
7
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Aeromonas hydrophila infection
|
disease |
|
Disease or Syndrome
|
16
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Vitamin D Deficiency
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
153
|
37
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Chronic rhinosinusitis with nasal polyps
|
disease |
|
Neoplastic Process
|
168
|
1
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Malignant neoplasm of skin
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
508
|
38
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |